Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Ownership

$3.88

$0.12 (-3%)
Last update: 01:00 PM EST
Day's range
$3.86
Day's range
$4.07

Contineum Therapeutics, Inc. Class A Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JOHNSON & JOHNSON 05/07/2025 1.98 M $13.81 M   0.00% 7.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 1.72 M $12.01 M   0.00% 6.65%
FRANKLIN RESOURCES INC 05/13/2025 1.58 M $11.00 M   9.04% 6.09%
PERCEPTIVE ADVISORS LLC 05/15/2025 1.44 M $10.06 M   0.00% 5.57%
FMR LLC 05/12/2025 810.32 K $5.66 M   17.12% 3.13%
VANGUARD GROUP INC 05/09/2025 803.43 K $5.61 M   -0.70% 3.11%
SECTORAL ASSET MANAGEMENT INC 05/15/2025 800.79 K $5.59 M   0.00% 3.10%
HHLR ADVISORS, LTD. 05/15/2025 669.34 K $4.67 M   0.00% 2.59%
BLACKROCK, INC. 05/02/2025 616.62 K $4.30 M   2.16% 2.38%
SAMSARA BIOCAPITAL, LLC 05/15/2025 588.82 K $4.11 M   0.00% 2.28%
SATURN V CAPITAL MANAGEMENT LLC 05/15/2025 560.98 K $3.92 M   -2.10% 2.17%
BAKER BROS. ADVISORS LP 05/15/2025 312.50 K $2.18 M   0.00% 1.21%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 193.05 K $1.35 M   2.46% 0.75%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 168.77 K $1.18 M   105.23% 0.65%
CASDIN CAPITAL, LLC 05/15/2025 148.33 K $1.04 M   -50.00% 0.57%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 142.20 K $992.56 K   12.86% 0.55%
SQUAREPOINT OPS LLC 05/15/2025 131.03 K $914.57 K   -39.69% 0.51%
STATE STREET CORP 05/15/2025 126.86 K $885.51 K   1.70% 0.49%
NORTHERN TRUST CORP 05/13/2025 83.63 K $583.71 K   -6.31% 0.32%
MORGAN STANLEY 05/15/2025 57.16 K $398.96 K   115.23% 0.22%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 51.20 K $357.39 K   -7.46% 0.20%
JANUS HENDERSON GROUP PLC 05/15/2025 42.50 K $300.47 K   -37.79% 0.16%
MARSHALL WACE, LLP 05/15/2025 31.08 K $216.97 K   186.86% 0.12%
STRATEGIES WEALTH ADVISORS, LLC 05/14/2025 25.00 K $174.50 K   0.00% 0.10%
BANK OF NEW YORK MELLON CORP 04/29/2025 19.90 K $138.90 K   6.20% 0.08%
DYNAMIC TECHNOLOGY LAB PRIVATE LTD 05/16/2025 16.84 K $118.00 K   100.00% 0.07%
DEUTSCHE BANK AG\ 05/09/2025 16.08 K $112.23 K   0.00% 0.06%
GOLDMAN SACHS GROUP INC 06/27/2025 14.22 K $99.26 K   -46.06% 0.06%
05/12/2025 13.31 K $92.88 K   100.00% 0.05%
UBS GROUP AG 05/13/2025 13.29 K $92.79 K   -46.57% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 13.26 K $92.53 K   100.00% 0.05%
BARCLAYS PLC 05/15/2025 11.08 K $77.00 K   -31.95% 0.04%
WELLS FARGO & COMPANY/MN 05/13/2025 10.88 K $75.92 K   1.13% 0.04%
RHUMBLINE ADVISERS 05/29/2025 7.57 K $52.85 K   -8.02% 0.03%
CITIGROUP INC 05/12/2025 7.39 K $51.56 K   -10.75% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 6.09 K $42.54 K   3.99% 0.02%
BANK OF AMERICA CORP /DE/ 05/15/2025 5.77 K $40.27 K   -36.83% 0.02%
JPMORGAN CHASE & CO 05/12/2025 5.17 K $36.07 K   -81.82% 0.02%
COREBRIDGE FINANCIAL, INC. 05/14/2025 5.14 K $35.87 K   -1.46% 0.02%
STRS OHIO 05/28/2025 3.90 K $27.22 K   0.00% 0.02%
LEGAL & GENERAL GROUP PLC 05/15/2025 3.63 K $25.34 K   0.00% 0.01%
05/09/2025 1.40 K $9.74 K   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 1.36 K $9.48 K   44.01% 0.01%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 05/15/2025 783 $5.47 K   0.00% 0.00%
AMERITAS INVESTMENT PARTNERS, INC. 05/12/2025 680 $4.75 K   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 628 $4.38 K   -52.32% 0.00%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 600 $4.00 K   0.00% 0.00%
CWM, LLC 05/01/2025 415 $3.00 K   100.00% 0.00%
AMALGAMATED BANK 04/25/2025 362 $3.00 K   50.83% 0.00%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 318 $2.22 K   100.00% 0.00%

Contineum Therapeutics, Inc. Class A Common Stock institutional Ownership - FAQ's

During the previous two years, 65 institutional investors and hedge funds held shares of Contineum Therapeutics, Inc. Class A Common Stock. The most heavily invested institutionals were:

JOHNSON & JOHNSON: 1.98 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 1.72 M

FRANKLIN RESOURCES INC: 1.58 M

PERCEPTIVE ADVISORS LLC: 1.44 M

FMR LLC: 810,317

VANGUARD GROUP INC: 803,428

52.44% of Contineum Therapeutics, Inc. Class A Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 13.83 M shares in the last 24 months. This purchase volume represents approximately $53.64 M in transactions.